Medications for Orthostatic Hypotension
14 results
Droxidopa (droxidopa)
(Droxidopa)CivicaScript LLC
Usage: Droxidopa capsules are indicated for treating orthostatic dizziness and lightheadedness in adults with symptomatic neurogenic orthostatic hypotension due to conditions like Parkinson's disease, multiple system atrophy, and non-diabetic autonomic neuropathy. Effectiveness beyond two weeks has not been established and should be periodically assessed.
Droxidopa (droxidopa)
(Droxidopa)MSN LABORATORIES PRIVATE LIMITED
Usage: Droxidopa capsules are indicated for treating orthostatic dizziness and lightheadedness in adults with symptomatic neurogenic orthostatic hypotension due to conditions like Parkinson's disease, multiple system atrophy, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy. Effectiveness beyond 2 weeks has not been established.
Droxidopa (droxidopa)
(droxidopa)Sun Pharmaceutical Industries, Inc.
Usage: Droxidopa capsules are indicated for treating orthostatic dizziness and lightheadedness in adult patients with symptomatic neurogenic orthostatic hypotension due to conditions like Parkinson's disease, multiple system atrophy, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy. Effectiveness beyond 2 weeks is not established.
Droxidopa (droxidopa)
(Droxidopa)Novadoz Pharmaceuticals LLC
Usage: Droxidopa capsules are indicated for treating orthostatic dizziness and lightheadedness in adults with symptomatic neurogenic orthostatic hypotension due to conditions like Parkinson's disease, multiple system atrophy, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy. Long-term effectiveness is not established and should be periodically reassessed.
Droxidopa (droxidopa)
(Droxidopa)Ajanta Pharma USA Inc.
Usage: Droxidopa capsules are indicated for treating orthostatic dizziness, lightheadedness, or a pre-blackout sensation in adults with symptomatic neurogenic orthostatic hypotension due to conditions like Parkinson's disease, multiple system atrophy, and others. Effectiveness beyond 2 weeks has not been established.
Midodrine hydrochloride (midodrine hydrochloride)
(Midodrine Hydrochloride)Rising Pharmaceuticals, Inc.
Usage: Midodrine hydrochloride tablets are indicated for treating symptomatic orthostatic hypotension in patients whose lives are significantly impaired despite standard care. Its use is based on effects on standing blood pressure, though clinical benefits have yet to be established. Continued use requires significant symptomatic improvement.
Midodrine hydrochloride (midodrine hydrochloride)
(MIDODRINE HYDROCHLORIDE)Carilion Materials Management
Usage: Midodrine hydrochloride tablets are indicated for treating symptomatic orthostatic hypotension in patients whose quality of life is significantly impaired despite standard care. Its use is based on its ability to increase standing systolic blood pressure, although clinical benefits have yet to be established, pending further trials.
Midodrine hydrochloride (midodrine hydrochloride)
(Midodrine Hydrochloride)AvPAK
Usage: Midodrine hydrochloride is indicated for symptomatic orthostatic hypotension in patients whose lives are significantly impaired despite standard care. It is intended to increase standing systolic blood pressure, although clinical benefits have yet to be established. Treatment should continue only if patients report significant improvement.
Midodrine hydrochloride (midodrine hydrochloride)
(MIDODRINE HYDROCHLORIDE)Alembic Pharmaceuticals Inc.
Usage: Midodrine hydrochloride tablets are indicated for treating symptomatic orthostatic hypotension in patients whose condition significantly impairs their daily life despite standard care. Although it increases standing systolic blood pressure, clinical benefits have not yet been established and require further investigation. Treatment should continue only with reported symptomatic improvement.
Midodrine hydrochloride (midodrine hydrochloride)
(Midodrine Hydrochloride)Par Pharmaceutical, Inc.
Usage: Midodrine hydrochloride tablets are indicated for treating symptomatic orthostatic hypotension in patients whose lives are significantly impaired despite standard care. While it may improve standing blood pressure, its clinical benefits are not yet established and further trials are ongoing. Treatment should continue only with reported symptomatic improvement.